GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
GILEAD SCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$153.07−3.12 (-2.00%)
Close on Oct 19, 2026
- Market cap
- $190.27B
- P/E (TTM)
- –
- Dividend yield
- 2.06%
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Feb 27, 2013(first seen in filings) | 2-for-1 | Earlier per-share figures divided by 2 |
| Jan 28, 2013 | 2-for-1 | Earlier per-share figures divided by 2 |
| Jun 25, 2007 | 2-for-1 | Earlier per-share figures divided by 2 |
| Sep 7, 2004 | 2-for-1 | Earlier per-share figures divided by 2 |
| Mar 8, 2002 | 2-for-1 | Earlier per-share figures divided by 2 |
| Feb 22, 2001 | 2-for-1 | Earlier per-share figures divided by 2 |